Cleared Special

K143549 - Vivorte Trabexus
(FDA 510(k) Clearance)

Jan 2015
Decision
30d
Days
Class 2
Risk

K143549 is an FDA 510(k) clearance for the Vivorte Trabexus. This device is classified as a Filler, Bone Void, Calcium Compound (Class II - Special Controls, product code MQV).

Submitted by Vivorte, Inc. (Louisville, US). The FDA issued a Cleared decision on January 14, 2015, 30 days after receiving the submission on December 15, 2014.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K143549 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 15, 2014
Decision Date January 14, 2015
Days to Decision 30 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MQV — Filler, Bone Void, Calcium Compound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045

Similar Devices — MQV Filler, Bone Void, Calcium Compound

All 488
Adaptos?Fuse Bone Graft
K253524 · Biomendex OY · Feb 2026
FIBERGRAFT? BG Putty GPS Bone Graft Substitute FIBERGRAFT? BG Putty Bone Graft Substitute FIBERGRAFT? AERIDYAN? Matrix Bone Graft Substitute FIBERGRAFT? BG Matrix Bone Graft Substitute
K253147 · Prosidyan, Inc. · Oct 2025
Mg OSTEOINJECT?; Mg OSTEOREVIVE?; Mg OSTEOCRETE?
K251522 · Bone Solutions, Inc. · Oct 2025
Allomatrix (Allomatrix Injectable Putty; Allomatrix C; Allomatrix DR; Allomatrix Custom)
K252085 · Wright Medical Technology, Inc. (Stryker Corporation) · Sep 2025
Device 300423 Granules
K251556 · Geistlich Pharma AG · Jul 2025
OsteoFlo HydroFiber
K251720 · SurGenTec, LLC · Jul 2025